




AngioDynamics Cancels Participation in 2011 RBC Capital Markets Healthcare Conference
ALBANY, N.Y.--([ BUSINESS WIRE ])--AngioDynamics (NASDAQ:ANGO), a leading provider of innovative medical devices for the minimally-invasive treatment of cancer and peripheral vascular disease, announced today that Joseph Gersuk, Executive Vice President and Chief Financial Officer, will not be able to present at the RBC Capital Markets Healthcare Conference on Wednesday, March 2, 2011, due to minor injuries sustained in a recent accident.
"This development combined with a scheduling conflict that prevents my participation leads us to cancel our scheduled presentation at the RBC healthcare conference."
aWhile Joe remains able to fulfill his daily responsibilities as CFO, he recently sustained minor injuries in an accident that prevent him from traveling,a said Jan Keltjens, AngioDynamics President and CEO. aThis development combined with a scheduling conflict that prevents my participation leads us to cancel our scheduled presentation at the RBC healthcare conference.a
About AngioDynamics
AngioDynamics, Inc. is a leading provider of innovative medical devices used by interventional radiologists, surgeons and other physicians for the minimally-invasive treatment of cancer and peripheral vascular disease. AngioDynamicsa™ diverse product lines include market-leading ablation systems, vascular access products, angiographic products and accessories, dialysis products, angioplasty products, drainage products, thrombolytic products, embolization products and venous products. More information is available at [ www.angiodynamics.com ].